- Study at RCSI
- Student Life
- Schools & Faculties
- Faculty of Medicine & Health Sciences
- School of Medicine
- School of Pharmacy
- School of Physiotherapy
- School of Nursing & Midwifery
- School of Postgraduate Studies
- Institute of Leadership
- Student, Academic & Regulatory Affairs
- Health Professions Education Centre (HPEC)
- Academic Departments
- Faculty of Sports and Exercise Medicine
- Faculty of Nursing & Midwifery
- Faculty of Dentistry
- Faculty of Radiologists
- Surgical Affairs
- Research & Innovation
- Strategic Academic Recruitment Programme
- Research News & Events
- Research Areas
- Principal Investigators
- Research Networks & Centres
- Technology Cores & Research Facilities
- Research Office
- Employment Opportunities
- PhD Projects and Postgraduate Training Opportunities
- Research Ethics
- Technology Transfer Office & Management of Intellectual Property
- Research by Faculty
- Research by Academic Department
- Research by School
- Human Resources Strategy for Researchers (HRS4R)
- About RCSI
- CEO and Senior Management
- Annual Report
- 3U Partnership
- Contact us and location
- Venue hire
- New academic and education building
- RCSI and the wider community
- Quality Enhancement Office
- Academic Health Centre
- Irish Society of Urology
- Freedom of Information (FOI)
- Faculty of Medicine & Health Sciences Strategy 2013 - 2017
- Medical Validation Ireland
- RCSI International
PhD: Maria Morgan - Molecular & Cellular Therapeutics
This project will address the role of hydroxyapatite in M1/M2 macrophage differentiation and the potential biological consequences of hydroxyapatite-derived macrophages in exacerbating tumor progression.
Breast cancer microcalcification-induced local inflammation; potential consequences for tumour progression
Radiographic mammary microcalcifications constitute one of the most important diagnostic markers of both benign and malignant lesions of the breast. Up to 50% of all nonpalpable breast cancers are detected solely through microcalcifications presenting during a mammogram scan and up to 93% of cases of ductal carcinoma in situ (DCIS) present with microcalcifications.
During the past decade, cases of subclinical cancer, that is, nonpalpable breast cancers detected by mammography, have accounted for a progressively increasing percentage of breast cancers. Although the diagnostic value of these microcalcifications in breast cancer is well established, their genesis is not clear.
With the exception of our recent publications, there have been no other reported investigations of the mechanism of calcium deposition or, the potential of differing mammary cell types to generate specific calcium mineral species.
No study to date has examined the pro-inflammatory potential of the deposited hydroxyapatite found associated with breast cancer. Furthermore, the potential for mineralisation and the microenvironment regulating it representing a significant feature of selected tumours has not even been considered. Many recent publications link initiation and recurrence of cancer to chronic inflammation.
Macrophages are well known for their role in the primary response to infection and injury, but recently they have been implicated in the pathogenesis of tumour progression. We hypothesise that microcalcifications in the form of hydroxyapatite deposits are potent pro-inflammatory molecules and that in this context they promote M1 differentiation and may contribute to tumor progression.
Thus this project will address (a) the role of hydroxyapatite in M1/M2 macrophage differentiation and (b) the potential biological consequences of hydroxyapatite-derived macrophages (and the cytokines they produce) in exacerbating tumor progression.